Table 3 Postoperative adverse events in the XEN63 and MicroShunt groups.
From: Xen 63 versus Preserflo MicroShunt implant in patients with primary open-angle glaucoma
AE | XEN63 | MicroShunt | p value |
|---|---|---|---|
Needling, n (%) | 3 (10.0) | 0 (0.0) | 0.0780 |
Surgical revision | 1 (3.3) | 1 (3.3) | 1.000 |
Device removal | 0 (0.0 | 1 (3.3) | 0.3198 |
Hypotonic maculopathy | 0 (0.0) | 1 (3.3)a | 0.3198 |
Hyphema | 1 (3.3)b | 0 (0.0) | 0.3198 |
Corneal Dellen | 1 (3.3)c | 0 (0.0) | 0.3198 |
Choroidal detachment | 0 (0.0) | 2 (6.7)d | 0.1538 |
